The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust - 02/04/21
Doi : 10.1016/j.jinf.2020.11.004
Thomas Gardiner a, ⁎ 
, Graham Cooke b, Sarah Fidler b, Nichola Cooper d, Louise Young a
, Graham Cooke b, Sarah Fidler b, Nichola Cooper d, Louise Young a a Imperial College Healthcare NHS Trust, London, W2 1NY, United Kingdom
b Department of Infectious Diseases, Faculty of Medicine, Imperial College, London, SW7 2AZ, United Kingdom
d Department of Immunology and Inflammation, Faculty of Medicine, Imperial College, London, SW7 2AZ, United Kingdom
⁎Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | BAME patients were under-represented in the Recovery trial at ICHT. |
• | There are likely many factors responsible, requiring a multipartner response. |
• | Local research teams need more support and resources to help maximize inclusivity. |
© 2020
Publié par Elsevier Masson SAS.
Vol 82 - N° 4
P. 84-123 - avril 2021 Retour au numéro
Article précédent
- Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation
- Yan Yan, Xiufeng Jiang, Juanjuan Fu, Jiehui Huang, Yuanwang Qiu, Difei Ding, Lina Ge, Hao Zhang, Lihua Huang, Xiaojie Lu, Qinxue Hu
- Comparing SARS-CoV-2 and influenza A(H1N1)pdm09-infected patients requiring ECMO – A single-centre, retrospective observational cohort experience
- Matthew Charlton, Susan Dashey, Abigail Stubbs, Florence YL Lai, Paul W Bird, Vinay Badhwar, Julian W Tang
Bienvenue sur EM-consulte, la référence des professionnels de santé.